Lung cancer is likely to surpass breasts cancers as the primary cause of cancer loss of life among Western females by the middle of this decade, according to new research released in cancer publication History of Oncology. In the UK and Belgium, it has already overtaken breasts cancers as the primary cause of cancer deaths in females.
The research by scientists in Tuscany and Europe forecasts that just over 1.3 thousand individuals will die from cancer (737,747 men and 576,489 women) in the 27 nations of the Western Partnership in 2013. Although the real figures have improved when in contrast to 2009 (the season for which there are World Health Company death rate information for most EU countries), the amount (age-standardised per 100,000 populations) of individuals who die from the illness has dropped. Since 2009 there has been 6% drop among men and 4% drop among females.
However, despite the decrease in cancer deaths overall, lung cancer loss of life rates keep increase among females in all nations, while breasts cancers rates drop. In 2013 there will be an approximated 88,886 deaths (14.6 per 100,000 women) from breasts cancers and 82,640 deaths (14 per 100,000 women) from lung cancer. Lung Cancer deaths have increased by 7% among females since 2009.
“This expected rise of women lung cancer in the UK may indicate the improved occurrence of younger ladies beginning cigarette smoking in the delayed 60s and 70s, possibly due to modifying socio-cultural behaviour at that time. However, less young ladies these days in the UK and elsewhere in European countries are cigarette smoking and, therefore, deaths from lung cancer may start to level off after 2020 at around 15 per 100,000 females.”
Deaths from breasts cancers have been decreasing continuously, with a 7% drop in rates since 2009 in the EU.
Although the lung cancer is still the primary cause of cancer loss of life among men, with nearly 187,000 deaths expected for 2013, providing a loss of life amount of 37.2 per 100,000 men, this symbolizes a 6% drop since 2009.
The research considered cancer rates in the whole of the EU (27 member states as at 2007) and also in six individual nations – Poland, Germany, Italy, Spain, France and the UK – for all cancers, and, independently, for abdomen, intestine, pancreatic, lung, prostate, breasts, uterus (including cervix) and leukaemias. This is the third successive season the scientists have released expected EU cancer deaths. Last season they expected deaths for 2012.
The scientists targeted on intestinal cancers, particularly colorectal tract cancers, for their 2013 forecasts. They found that, overall; there has been a decrease in rates of deaths from intestinal tract cancers in the EU. They estimate there will be 87,818 deaths (16.7 per 100,000) in men and 75,059 (9.5 per 100,000) in females in 2013; this symbolizes a drop when in contrast to real loss of life rates of 17.6 for men and 10.5 for females for the period 2005-2009.
However, there are large modifications between European countries. Poland and Spain have the biggest rates of colorectal cancer deaths among men, with rates well above the EU average at 21.5 and 18.6 per 100,000 men respectively. Death rates among Polish females are also greater than the EU average, at 10.8; Spanish females have loss of life rates from abdominal tract cancers that are reduced than the EU average at 9 per 100,000 females.
Pancreatic cancer is the only cancer for which loss of life rates are not expected to decrease in both genders and, in fact, may rise in 2013. There will be an expected 40,069 deaths (8 per 100,000) in men and 40,197 deaths (5.5 per 100,000) in females in 2013. These rates are greater than those documented for 2009 of 7.9 per 100,000 in men and 5.4 per 100,000 in females. Among females in Germany the loss of life amount will be greater (6.3 per 100,000), while it will be reduced among Spanish females (4.1 per 100,000) as opposed to EU average. Men in France have the biggest expected amount (8.7 per 100,000), while the other nations in the research had more constant rates among men, with Spain and the UK having reduced rates (6.6 per 100,000) than the EU average.